Literature DB >> 9002417

Correlation between self-reported cocaine use and urine toxicology in an inner-city prenatal population.

M K Lindsay1, S Carmichael, H Peterson, J Risby, H Williams, L Klein.   

Abstract

To determine the prevalence of recent cocaine use and the accuracy of self-reported use, the results of a urine assay for the major cocaine metabolite benzoylecgonine were compared with self-reported cocaine use in an inner-city prenatal population offered routine voluntary urine toxicology screening at the time of registration for prenatal care. During a 1-year period, 6866 women registered for prenatal care and 5200 (76%) consented to urine assays for cocaine metabolites. Of the women consenting to urine assays, 253 (5%) had positive assays for benzoylecgonine. Women with positive assays were significantly more likely than those with negative assays to be older (mean [SD] 27 [5] versus 23 [6] years), black, single, and unemployed. In addition, women with positive assays were significantly more likely to be multiparous, report > two sexual partners in the previous year, and acknowledge a history of a sexually transmitted disease (STD). Forty-seven percent of women with positive assays acknowledged cocaine use in the 6 months prior to sampling. Women with positive assays who denied cocaine use were significantly more likely than those who admitted use to be younger (mean [SD] 26 [5] versus 28 [4] years), to report > or = two sexual partners in the past year, and acknowledge a history of an STD. This analysis revealed a poor correlation between self-reported cocaine use and the results of urine assays for cocaine metabolites among women seeking prenatal care in an inner-city institution.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9002417      PMCID: PMC2608186     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  12 in total

1.  Epidemiologic characteristics of drug use during pregnancy: experience in a Nashville hospital.

Authors:  P S Cartwright; J O Schorge; F J McLaughlin
Journal:  South Med J       Date:  1991-07       Impact factor: 0.954

2.  Cocaine abuse during pregnancy: maternal and fetal implications.

Authors:  B B Little; L M Snell; V R Klein; L C Gilstrap
Journal:  Obstet Gynecol       Date:  1989-02       Impact factor: 7.661

3.  Cocaine abuse during pregnancy: peripartum prevalence and perinatal outcome.

Authors:  M G Neerhof; S N MacGregor; S S Retzky; T P Sullivan
Journal:  Am J Obstet Gynecol       Date:  1989-09       Impact factor: 8.661

4.  The perinatal impact of cocaine, amphetamine, and opiate use detected by universal intrapartum screening.

Authors:  K M Gillogley; A T Evans; R L Hansen; S J Samuels; K K Batra
Journal:  Am J Obstet Gynecol       Date:  1990-11       Impact factor: 8.661

5.  The relationship of cocaine use to syphilis and human immunodeficiency virus infections among inner city parturient women.

Authors:  H L Minkoff; S McCalla; I Delke; R Stevens; M Salwen; J Feldman
Journal:  Am J Obstet Gynecol       Date:  1990-08       Impact factor: 8.661

6.  Cocaine use during pregnancy: prevalence and correlates.

Authors:  D A Frank; B S Zuckerman; H Amaro; K Aboagye; H Bauchner; H Cabral; L Fried; R Hingson; H Kayne; S M Levenson
Journal:  Pediatrics       Date:  1988-12       Impact factor: 7.124

7.  Cocaine use during pregnancy: adverse perinatal outcome.

Authors:  S N MacGregor; L G Keith; I J Chasnoff; M A Rosner; G M Chisum; P Shaw; J P Minogue
Journal:  Am J Obstet Gynecol       Date:  1987-09       Impact factor: 8.661

8.  High prevalence of recent cocaine use and the unreliability of patient self-report in an inner-city walk-in clinic.

Authors:  S E McNagny; R M Parker
Journal:  JAMA       Date:  1992-02-26       Impact factor: 56.272

9.  Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance.

Authors:  I Zavaroni; E Bonora; M Pagliara; E Dall'Aglio; L Luchetti; G Buonanno; P A Bonati; M Bergonzani; L Gnudi; M Passeri
Journal:  N Engl J Med       Date:  1989-03-16       Impact factor: 91.245

10.  Crack cocaine: a risk factor for human immunodeficiency virus infection type 1 among inner-city parturients.

Authors:  M K Lindsay; H B Peterson; J Boring; J Gramling; S Willis; L Klein
Journal:  Obstet Gynecol       Date:  1992-12       Impact factor: 7.661

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.